With genetic test spending under the microscope, CMS is asking labs to help shape future anti-fraud rules—before formal proposals are…
Read More
CMS Launches Sweeping Anti-Fraud Initiative, Targeting Genetic Testing Spending and Soliciting Lab Industry Input for Future Regulations
The Centers for Medicare and Medicaid Services (CMS) has embarked on a significant preemptive strike against healthcare fraud, initiating a…
Read More
